ALEXIS NEWSOME: Open Payments
NPI 1558140707 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 30 payments from 11 companies in 2025. Trend: 2023 $163 · 2024 $1,187 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $262 |
| Otsuka America Pharmaceutical, Inc. | 6 | $230 |
| Novo Nordisk Inc | 1 | $120 |
| Neurocrine BioSciences, Inc. | 5 | $111 |
| Alkermes, Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Lundbeck LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $29 |
Products named: ABILIFY MAINTENA, MOUNJARO, ZEPBOUND, Ozempic, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
